Twist Bioscience Corporation (TWST) — Analyst outlook / Analyst consensus target is. Based on 13 analyst ratings, the consensus is bullish — 10 Buy, 2 Hold, 1 Sell.
The consensus price target is $48.25 (low: $41.00, high: $52.00), representing a downside of 16% from the current price $57.41.
Analysts estimate Earnings Per Share (EPS) of $-3.72 and revenue of $0.31B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $-3.60 vs est $-3.72 (beat +3.2%). 2025: actual $-1.30 vs est $-1.31 (beat +1%). Analyst accuracy: 98%.
TWST Stock — 12-Month Price Forecast
$48.25
▼ -15.96% Downside
Average Price Target
Based on 13 Wall Street analysts offering 12-month price targets for Twist Bioscience Corporation, the average price target is $48.25, with a high forecast of $52.00, and a low forecast of $41.00.
The average price target represents a -15.96% change from the last price of $57.41.
Highest Price Target
$52.00
Average Price Target
$48.25
Lowest Price Target
$41.00
TWST Analyst Ratings
Buy
Based on 13 analysts giving stock ratings to Twist Bioscience Corporation in the past 3 months
EPS Estimates — TWST
98%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual –$3.60
vs Est –$3.72
▲ 3.3% off
2025
Actual –$1.30
vs Est –$1.31
▲ 1.0% off
Profitability Outlook
Company has been making losses in all recent fiscal years. EPS is improving but still negative. Analysts expect losses to continue near-term.
Revenue Estimates — TWST
99%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $0.313B
vs Est $0.311B
▲ 0.7% off
2025
Actual $0.377B
vs Est $0.375B
▲ 0.5% off
Revenue Trend
Moderate revenue growth trend. Analysts forecast revenue contraction ahead.
